lncRNA MCF2L-AS1/miR-105/ IL-1β Axis Regulates Colorectal Cancer Cell Oxaliplatin Resistance
Mao Cai,* Wanle Hu,* Chongjie Huang, Chongjun Zhou, Jiante Li, Yanyu Chen, Yaojun Yu Department of Anorectal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, People’s Republic of China*These authors contributed equally to this...
Guardado en:
Autores principales: | Cai M, Hu W, Huang C, Zhou C, Li J, Chen Y, Yu Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d67a3e648dc44e669615a185ce786683 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phytic acid potentiates oxaliplatin effects in colorectal cancer induced
by 1,2-DMH: the role of miR-224 and miR-200a
por: Tarek M. Okda, et al.
Publicado: (2021) -
A Novel Targeted Therapy System for Cervical Cancer: Co-Delivery System of Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier
por: Ye H, et al.
Publicado: (2021) -
Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
por: Qingguo Li, et al.
Publicado: (2021) -
Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
por: Li Y, et al.
Publicado: (2020) -
Antiangiogenic VEGF165b Expression in Human Breast MCF-7 and MCF-10A Cells Exposed to Reverse Transcriptase and Protease Inhibitors
por: Adefolaju,Gbenga Anthony, et al.
Publicado: (2017)